Optimal Management of Localized Renal Cell Carcinoma: Surgery, Ablation, or Active SurveillanceJournal of the National Comprehensive Cancer Network : JNCCN - Tập 7 Số 6 - Trang 635-643 - 2009
David Y.T. Chen, Robert G. Uzzo
Radical nephrectomy is historically accepted as standard treatment for localized renal cell carcinoma (RCC). However, the presentation of RCC has changed dramatically over the past 3 decades. Newer alternative interventions aim to reduce the negative impact of open radical nephrectomy, with the natural history of RCC now better understood. This article discusses current surgical and manage...... hiện toàn bộ
Chronic Myeloid Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in OncologyJournal of the National Comprehensive Cancer Network : JNCCN - Tập 18 Số 10 - Trang 1385-1415 - 2020
Michael W. Deininger, Neil P. Shah, Jessica K. Altman, Ellin Berman, Ravi Bhatia, Bhavana Bhatnagar, Daniel J. DeAngelo, Jason Gotlib, Gabriela Hobbs, Lori J. Maness, Monica Mead, Leland Metheny, Sanjay Mohan, Joseph O. Moore, Kiran Naqvi, Vivian G. Oehler, Arnel Pallera, Mrinal M. Patnaik, Keith W. Pratz, Iskra Pusic, Michal G. Rose, B. Douglas Smith, David S. Snyder, Kendra Sweet, Moshe Talpaz, James E. Thompson, David T. Yang, Kristina M. Gregory, Hema Sundar
Chronic myeloid leukemia (CML) is defined by the presence of Philadelphia chromosome (Ph) which results from a reciprocal translocation between chromosomes 9 and 22 [t(9;22] that gives rise to aBCR-ABL1fusion gene. CML occurs in 3 different phases (chronic, accelerated, and blast phase) and is usually diagnosed in the chronic phase. Tyros...... hiện toàn bộ
Non-Small Cell Lung Cancer GuidelinesJournal of the National Comprehensive Cancer Network : JNCCN - Tập 4 Số 6 - Trang 548 - 2006
David S. Ettinger, Gerold Bepler, Raphael Bueno, Andrew C. Chang, Joe Y. Chang, Lucian R. Chirieac, Thomas A. D’Amico, Todd L. Demmy, Steven J. Feigenberg, Frederic W. Grannis, Leena Gandhi, Mohammad Jahanzeb, Anne Kessinger, Ritsuko Komaki, Mark G. Kris, Corey J. Langer, Quynh‐Thu Le, Renato Martins, Gregory A. Otterson, Francisco Robert, David J. Sugarbaker, Douglas E. Wood
Lung cancer is still the leading cause of cancer death worldwide, and non-small cell lung cancer accounts for 80% to 85% of all lung cancer cases. Surgery, radiation therapy, and chemotherapy are the 3 modalities commonly used to treat patients with NSCLC and can be used either alone or in combination depending on the disease status. The 2006 NCCN Non-Small Cell Lung Cancer Guidelines prov...... hiện toàn bộ
NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 5.2018Journal of the National Comprehensive Cancer Network : JNCCN - Tập 16 Số 7 - Trang 807-821 - 2018
David S. Ettinger, Dara L. Aisner, Douglas E. Wood, Wallace Akerley, Jessica R. Bauman, Joe Y. Chang, Lucian R. Chirieac, Thomas A. D’Amico, Thomas J. Dilling, M.C. Dobelbower, Ramaswamy Govindan, Matthew A. Gubens, Mark Hennon, Leora Horn, Rudy P. Lackner, Michael Lanuti, Ticiana Leal, Rogério Lilenbaum, Jules Lin, Billy W. Loo, Renato Martins, Gregory A. Otterson, Sandip Pravin Patel, Karen L. Reckamp, Gregory J. Riely, Steven E. Schild, Theresa A. Shapiro, James Stevenson, Steven Swanson, Kurt W. Tauer, Stephen C. Yang, Kristina M. Gregory, Miranda Hughes
Chronic Myelogenous LeukemiaJournal of the National Comprehensive Cancer Network : JNCCN - Tập 7 Số 9 - Trang 984-1023 - 2009
S O'Brien, Ellin Berman, Hossein Borghaei, Daniel J. DeAngelo, Marcel P. Devetten, Steven M. Devine, Harry P. Erba, Jason Gotlib, Madan Jagasia, Joseph O. Moore, Tariq I. Mughal, Javier Pinilla‐Ibarz, Jerald P. Radich, Neil P. Shah, Paul J. Shami, Benjamin D. Smith, David S. Snyder, Martin S. Tallman, Moshe Talpaz, Meir Wetzler
NCCN Task Force Report: Estrogen Receptor and Progesterone Receptor Testing in Breast Cancer by ImmunohistochemistryJournal of the National Comprehensive Cancer Network : JNCCN - Tập 7 Số Suppl_6 - Trang S-1-S-21 - 2009
D. Craig Allred, Robert W. Carlson, Donald A. Berry, Harold J. Burstein, Stephen B. Edge, Lori J. Goldstein, Allen M. Gown, M. Elizabeth Hammond, J. Dirk Iglehart, Susan J. Moench, Lori J. Pierce, Peter M. Ravdin, Stuart J. Schnitt, Antonio C. Wolff
The NCCN Task Force on Estrogen Receptor and Progesterone Receptor Testing in Breast Cancer by Immunohistochemistry was convened to critically evaluate the extent to which the presence of the estrogen receptor (ER) and progesterone receptor (PgR) biomarkers in breast cancer serve as prognostic and predictive factors in the adjuvant and metastatic settings, and the ability of immunohistoche...... hiện toàn bộ
Breast CancerJournal of the National Comprehensive Cancer Network : JNCCN - Tập 7 Số 2 - Trang 122-192 - 2009
Robert W. Carlson, D. Craig Allred, Benjamin O. Anderson, Harold J. Burstein, W. Bradford Carter, Stephen B. Edge, John K. Erban, William B. Farrar, Lori J. Goldstein, William J. Gradishar, Daniel F. Hayes, Clifford A. Hudis, Mohammad Jahanzeb, Krystyna Kiel, Britt‐Marie Ljung, P. Kelly Marcom, Ingrid A. Mayer, Beryl McCormick, Lisle M. Nabell, Lori J. Pierce, Elizabeth Reed, Mary Lou Smith, George Somlo, Richard L. Theriault, Neal S. Topham, John H. Ward, Eric P. Winer, Antonio C. Wolff
Ung Thư Phổi Không Nhỏ Tế Bào, Phiên Bản 3.2022, Hướng Dẫn Thực Hành Lâm Sàng NCCN trong Ung Thư Dịch bởi AI Journal of the National Comprehensive Cancer Network : JNCCN - Tập 20 Số 5 - Trang 497-530 - 2022
David S. Ettinger, Douglas E. Wood, Dara L. Aisner, Wallace Akerley, Jessica R. Bauman, Ankit Bharat, Débora S. Bruno, Joe Y. Chang, Lucian R. Chirieac, Thomas A. D’Amico, Malcolm M. DeCamp, Thomas J. Dilling, Jonathan E. Dowell, Scott Gettinger, Travis E. Grotz, Matthew A. Gubens, Aparna Hegde, Rudy P. Lackner, Michael Lanuti, Jules Lin, Billy W. Loo, Christine M. Lovly, Fabien Maldonado, Erminia Massarelli, Daniel Morgensztern, Thomas Ng, Gregory A. Otterson, Jose M. Pacheco, Sandip Pravin Patel, Gregory J. Riely, Jonathan W. Riess, Steven E. Schild, Theresa A. Shapiro, Aditi P. Singh, James Stevenson, Alda L. Tam, Tawee Tanvetyanon, Jane Yanagawa, Stephen C. Yang, Edwin Yau, Kristina M. Gregory, Miranda Hughes
Các Hướng dẫn Thực hành Lâm sàng NCCN về Ung thư (Hướng dẫn NCCN) cho Ung Thư Phổi Không Nhỏ Tế Bào (NSCLC) đưa ra các biện pháp quản lý được khuyến nghị cho bệnh nhân mắc NSCLC, bao gồm chẩn đoán, điều trị chính, giám sát hồi phục và điều trị tiếp theo. Bệnh nhân ung thư phổi di căn có đủ điều kiện để thực hiện các liệu pháp nhắm mục tiêu hoặc liệu pháp miễn dịch hiện đang có thời gian s...... hiện toàn bộ